| Characterisation of Anopheles gambiae heme oxygenase and metalloporphyrin feeding suggests a potential role in reproduction CS Spencer, C Yunta, GPG de Lima, K Hemmings, LY Lian, G Lycett, ... Insect biochemistry and molecular biology 98, 25-33, 2018 | 14 | 2018 |
| Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12‐lead Holter B Mendzelevski, CS Spencer, A Freier, D Camilleri, C Graff, J Täubel Annals of Noninvasive Electrocardiology 26 (5), e12851, 2021 | 6 | 2021 |
| Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers J Täubel, U Lorch, G Ferber, CS Spencer, A Freier, S Coates, ... British Journal of Clinical Pharmacology 88 (1), 128-137, 2022 | 3 | 2022 |
| A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity J Täubel, A Mazzetti, G Ferber, W Burch, S Fernandes, A Patel, ... Clinical Pharmacology in Drug Development 10 (6), 572-581, 2021 | 2 | 2021 |
| Safety, Tolerability, and Dose Proportionality of a Novel Transdermal Fentanyl Matrix Patch and Bioequivalence With a Matrix Fentanyl Patch: Two Phase 1 Single‐Center Open … U Lorch, T Pierscionek, A Freier, CS Spencer, J Täubel Clinical Pharmacology in Drug Development 10 (3), 260-271, 2021 | 2 | 2021 |
| Fatty liver disease and improved clinical trial participant stratification J Taubel, J Mitchell, C Spencer, I Garitaonandia, U Lorch BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 87 (12), 4905-4906, 2021 | | 2021 |
| Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers J Täubel, U Lorch, CS Spencer, A Freier, D Camilleri, D Djumanov, ... Scientific Reports 11 (1), 6404, 2021 | | 2021 |
| DO DIFFERENT INSULIN REGIMES MODULATE THE EFFECT OF HYPERGLYCAEMIA AND HERG-BLOCKING AGENTS ON QTC INTERVAL? J Taubel, S Cole, H Wibberley, D Camilleri, C Spencer, A Freier, J Camm CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S6-S6, 2021 | | 2021 |
| Can a second booster dose be delayed in patients who have had COVID-19?(preprint) J Taubel, C Spencer, A Freier, D Camilleri, I Garitaonandia, U Lorch | | 2021 |
| Longitudinal analysis of COVID-19 infection rates and antibody levels pre-and post-vaccination J Taubel, ST Cole, CS Spencer, A Freier, I Atkin, I Garitaonandia, U Lorch European Journal of Clinical Pharmacology, 11-11, 2021 | | 2021 |
| A population pharmacokinetic approach to analysis of IgG levels in SARS-CoV-2-positive individuals J Taubel, S Cole, D Camilleri, C Spencer, A Freier, U Lorch British Journal of Pharmacology, 391-391, 2021 | | 2021 |
| The case for lowered positivity threshold for COVID-19 antibody screening tests J Taubel, S Cole, D Camilleri, C Spencer, A Freier, U Lorch British Journal of Clinical Pharmacology, 1618-1619, 2021 | | 2021 |
| Why the SARS-CoV-2 antibody test results may be misleading: insights from a longitudinal analysis of COVID-19 (preprint) J Taubel, ST Cole, CS Spencer, A Freier, D Camilleri, U Lorch | | 2020 |
| and Jörg Täubel1, 3 U Lorch, T Pierscionek, A Freier, CS Spencer | | 2020 |
| Do post-COVID-19 patients need a second dose of vaccine? J Taubel, CS Spencer, A Freier, D Camilleri, I Garitaonandia, U Lorch | | |
mark paineLiverpool School of Tropical MedicineVerified email at lstmed.ac.uk
